These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Retinopathy and hypertension affect serum high-sensitivity C-reactive protein levels in Type 2 diabetic patients. Tsunoda K, Arita M, Yukawa M, Ueyama M, Furuta M, Nakagawa T, Nanjo K, Sanke T. J Diabetes Complications; 2005; 19(3):123-7. PubMed ID: 15866055 [Abstract] [Full Text] [Related]
4. A decrease in VEGF and inflammatory markers is associated with diabetic proliferative retinopathy. Blum A, Socea D, Ben-Shushan RS, Keinan-Boker L, Naftali M, Segol G, Tamir S. Eur Cytokine Netw; 2012; 23(4):158-62. PubMed ID: 23328414 [Abstract] [Full Text] [Related]
5. Inflammatory markers in hypertensive patients and influence of some associated metabolic risk factor. Mitu F, Rezuş E, Banu C, Jufă C, Mitu O, Dima-Cozma C. Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):631-6. PubMed ID: 25341276 [Abstract] [Full Text] [Related]
6. High-sensitivity C-reactive protein: a novel cardiovascular risk predictor in type 2 diabetics with normal lipid profile. Asegaonkar SB, Marathe A, Tekade ML, Cherekar L, Bavikar J, Bardapurkar J, Ajay R. J Diabetes Complications; 2011; 25(6):368-70. PubMed ID: 22055258 [Abstract] [Full Text] [Related]
7. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status. Gui MH, Hong J, Lü AK, Chen Y, Shen WF, Li XY, Ning G. Chin Med J (Engl); 2008 Dec 20; 121(24):2509-16. PubMed ID: 19187587 [Abstract] [Full Text] [Related]
9. The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus. Kadoglou NP, Iliadis F, Angelopoulou N, Perrea D, Ampatzidis G, Liapis CD, Alevizos M. Eur J Cardiovasc Prev Rehabil; 2007 Dec 20; 14(6):837-43. PubMed ID: 18043308 [Abstract] [Full Text] [Related]
10. Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus. Mojahedi MJ, Bonakdaran S, Hami M, Sheikhian MR, Shakeri MT, Aiatollahi H. Iran J Kidney Dis; 2009 Jan 20; 3(1):12-6. PubMed ID: 19377253 [Abstract] [Full Text] [Related]
12. Decrease in inflammatory cardiovascular risk markers in hyperlipidemic diabetic patients treated with fenofibrate. Wu TJ, Ou HY, Chou CW, Hsiao SH, Lin CY, Kao PC. Ann Clin Lab Sci; 2007 Jan 20; 37(2):158-66. PubMed ID: 17522372 [Abstract] [Full Text] [Related]
13. High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome. Aso Y, Wakabayashi S, Nakano T, Yamamoto R, Takebayashi K, Inukai T. Metabolism; 2006 Aug 20; 55(8):1014-21. PubMed ID: 16839835 [Abstract] [Full Text] [Related]
15. Relationships between serum osteocalcin levels versus blood glucose, insulin resistance and markers of systemic inflammation in central Indian type 2 diabetic patients. Sarkar PD, Choudhury AB. Eur Rev Med Pharmacol Sci; 2013 Jun 20; 17(12):1631-5. PubMed ID: 23832730 [Abstract] [Full Text] [Related]
19. Candesartan effect on inflammation in hypertension. Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, Palumbo I, D'Angelo A, Cicero AF. Hypertens Res; 2010 Mar 20; 33(3):209-13. PubMed ID: 20075928 [Abstract] [Full Text] [Related]
20. Body mass and atherogenic dyslipidemia as major determinants of blood levels of B-type natriuretic peptides in Arab subjects with acute coronary syndromes. Akanji AO, Suresh CG, Al-Radwan R, Fatania HR. Metab Syndr Relat Disord; 2009 Dec 20; 7(6):563-9. PubMed ID: 19642911 [Abstract] [Full Text] [Related] Page: [Next] [New Search]